美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=CEPHALEXIN
符合检索条件的记录共76
8 页 当前第 1 页  下一页 最后一页 返回检索页
1药品名称CEPHALEXIN
申请号061969产品号001
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 250MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
2药品名称CEPHALEXIN
申请号061969产品号002
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 500MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构IVAX PHARMACEUTICALS INC SUB TEVA PHARMACEUTICALS USA
3药品名称CEPHALEXIN
申请号062117产品号001
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格EQ 100MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FACTA FARMACEUTICI SPA
4药品名称CEPHALEXIN
申请号062117产品号002
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格EQ 125MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FACTA FARMACEUTICI SPA
5药品名称CEPHALEXIN
申请号062117产品号003
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径FOR SUSPENSION;ORAL规格EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons*
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FACTA FARMACEUTICI SPA
6药品名称CEPHALEXIN
申请号062118产品号001
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 250MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FACTA FARMACEUTICI SPA
7药品名称CEPHALEXIN
申请号062118产品号002
活性成分CEPHALEXIN市场状态停止上市
剂型或给药途径CAPSULE;ORAL规格EQ 500MG BASE
治疗等效代码参比药物
批准日期Approved Prior to Jan 1, 1982申请机构FACTA FARMACEUTICI SPA
8药品名称CEPHALEXIN
申请号062702产品号001
活性成分CEPHALEXIN市场状态处方药
剂型或给药途径CAPSULE;ORAL规格EQ 250MG BASE
治疗等效代码AB参比药物
批准日期1987/02/13申请机构TEVA PHARMACEUTICALS USA INC
9药品名称CEPHALEXIN
申请号062702产品号002
活性成分CEPHALEXIN市场状态处方药
剂型或给药途径CAPSULE;ORAL规格EQ 500MG BASE
治疗等效代码AB参比药物
批准日期1987/02/13申请机构TEVA PHARMACEUTICALS USA INC
10药品名称CEPHALEXIN
申请号062703产品号001
活性成分CEPHALEXIN市场状态处方药
剂型或给药途径FOR SUSPENSION;ORAL规格EQ 125MG BASE/5ML
治疗等效代码AB参比药物
批准日期1987/02/13申请机构TEVA PHARMACEUTICALS USA INC